Clinical utility of breast pathology data: implications for practising pathologists.

Area of Science:

• Oncology
• Pathology

Background:

• Accurate breast cancer diagnosis and treatment rely heavily on pathology services.
• Pathology reports provide essential prognostic and predictive information for patient management.
• Minimum datasets (MDS) ensure consistency in pathology reporting.

Purpose of the Study:

• To highlight the critical role of pathology data in guiding breast cancer patient pathways.
• To illustrate the clinical utility of pathology information in treatment decisions, including neoadjuvant therapy.
• To provide examples of pathology data's application in personalized patient care.

Main Methods:

• Review of pathology reporting standards and minimum datasets.
• Analysis of clinical utility of pathology data in diagnostic and treatment pathways.
• Case examples demonstrating the impact of pathology findings on patient management.

Main Results:

• Pathology data is indispensable for confirmatory diagnosis and treatment planning in breast cancer.
• Minimum datasets enhance reporting consistency, but individual pathologist input is vital for tailored treatment.
• Pathology data plays a key role in determining patient management strategies, including neoadjuvant treatment.

Conclusions:

• Pathologists must understand the clinical utility of pathology data to optimize individual patient treatment.
• Pathology data informs critical decisions across the patient journey, from diagnosis to therapy.
• The principles discussed are applicable to future healthcare challenges, as demonstrated during the COVID-19 pandemic.